User Directories

investors Startups or Small Cap Companies others

Co-Hosts

Yao Yuan
POLSKY
SAPA

Conference Chair

Dr. Gui-Dong Zhu

President, Yao Yuan—Academy for Pharma Innovation; CEO, Sparx Therapeutics, Inc.

Symposium Steering Committee

Scott Brun, MD
Ex-Vice President, AbbVie, Former Head of AbbVie Ventures
Ka Yee Lee, Ph.D
Vice Provost for Research, Professor in Chemistry, the James Franck Institute, Institute for Biophysical Dynamics and the College, University of Chicago
Bala Srinivasan, Ph.D
Vice President for Strategy and Innovation and Chief International Officer, The University of Chicago
Gui-Dong Zhu, Ph.D
President, Yao Yuan—Academy for Pharma Innovation; CEO, Sparx Therapeutics, Inc.

Speakers

Keynote Bio-Partnering

Chad A Mirkin, Ph.D

George B. Rathmann Professor, Northwestern University; Member of All Three US National Academies, President’s Council of Advisors on Science & Technology (Obama Administration)

Alexis Borisy, Ph.D

Managing Partner, Third Rock Ventures, Chairman of Celsius Therapeutics、Tango Therapeutics、Relay Therapeutics

Bala Srinivasan, Ph.D

Vice President for Strategy and Innovation, Chief International Officer, Deputy Provost, The University of Chicago

Scientific Symposium​

Matthew Tirrell, Ph.D

Dean and Founding Pritzker Director of the Institute for Molecular Engineering, The University of Chicago

Alan Huang, Ph.D

CSO, Tango Therapeutics

Brian Blagg, Ph.D

Charles Huisking Professor of Chemistry and Biochemistry, University of Notre Dame

Bin Zhang, MD, PhD

Professor of Medicine, School of Medicine, Northwestern University

Lyu Aiping, Ph.D

Dean and Kennedy Y.H. Wong Professor, Hong Kong Baptist University , School of Chinese Medicine

Thomas von Geldern, Ph.D

President, Embedded Consulting

Program Highlights

Keynote Presentations

Dr. Chad A Mirkin, Ph.D, George B. Rathmann Professor, Northwestern University 

Dr. Alexis Borisy, Ph.D, Managing Partner, Third Rock Ventures

Bala Srinivasan, Ph.D, Vice President , The University of Chicago

Dr. Matthew Tirrell, Ph.D, Dean and Founding Pritzker Director of the Institute for Molecular Engineering, The University of Chicago

Dr. Brian Blagg, Ph.D, Charles Huisking Professor of Chemistry and Biochemistry, University of Notre Dame

Dr. Lyu Aiping, Dean and Kennedy Y.H. Wong Professor, Hong Kong Baptist University , School of Chinese Medicine

Up to 30

Renowned Venture Capitals and Investment Banks

30

Roadshow Presentations

Bio-partnering

And Matchmaking Activities

Scientific Symposium & Job Fair

Keynote Presentations, AbbVie, Abbott, Baxter, Pfizer participating

Tentative Agenda

If you can’t read clearly, please download a PDF version:

DateTimeEvent
29
May
2019

(Wednesday)

06:00 PM – 08:30 PMVIP dinner for speakers and invited guests
(Venue: Shaw’s Crab House, 1900 E. Higgins Rd, Schaumburg, IL 60173)
30
May
2019

(Thursday)

Bio- Partnering Forum
08:30 AM – 10:00 AMMORNING SESSION MODERATOR (Utopia Ballroom A&B)
Gui-Dong Zhu, Ph.D
President, Yao Yuan & CEO, Sparx Therapeutics
08:30 AM – 08:45 AMWelcome and Opening Remarks:
Gui-Dong Zhu, Ph.D
President, Yao Yuan & CEO, Sparx Therapeutics
08:45 AM – 09:00 AMSpecial Remarks:
Zhao Jian,
Consul General of Consulate General of the People’s Republic of China in Chicago
09:00 AM – 10:00 AMKeynote Address (1)
Chad A Mirkin, Ph.D 
George B. Rathmann Professor, Northwestern University
10:00 AM – 10:40 AMBreak & Networking
10:40 AM – 12:00 AMMODERATOR (Utopia Ballroom A&B)
Dr. Niels Emmerich, Vice President, Global Head Search and Evaluation, AbbVie

 

ROAD SHOW SESSION 
Track A

MODERATOR (Euphoria)
Dr. Mark Tang
Managing Partner
Good Health Capital

 

ROAD SHOW SESSION
Track B

10:40 AM – 11:00 AMMartin Welschof, CEO
BioInvent International
Dr. Jeff Hubbell
Eugene Bell Professor, UChicago
Arrow Immune
11:00 AM – 11:20 AMCarlos de Sousa, CEO
Immunicum
Dr. Jeff Hubbell
Eugene Bell Professor, UChicago
Morphogene
11:20 AM -11:40 AMMichael Flaschen, Head of Asia Strategy and Business Development
Aduro Biotech
Dr. Shouming Du, CEO
BrainXell
11:40 AM – 12:00 AMNeil Clark, CEO
Destiny Pharma
Dr. John Gong,CEO
3D Medicine Inc
12:00 PM – 01:20 PMMODERATOR (Utopia Ballroom C&D)
Dr. Anning Lin, Professor, The University of Chicago

 

Lunch w/Keynote Address (2,3)
Alexis Borisy, Ph.D
Managing Partner, Third Rock Ventures
Starr Marcello, MBA
Executive Director, Polsky Center for Innovation and Entrepreneurship, The University of Chicago

01:20 PM – 03:00 PMMODERATOR (Utopia Ballroom A&B)
Echo Hindle-Yang
CEO, MSQ Ventures

 

ROAD SHOW SESSION
Track A

MODERATOR (Euphoria)
Dr. Haipeng Cheng
Director, Sangel Capital &President, SAPA-MW

 

ROAD SHOW SESSION
Track B

01:20 PM – 01:40 PMDr. Wenbin Lin,
James Franck Professor, UChicago & Chairman,
Coordination Pharmaceuticals
Louis Laflamme, CEO & Director
Opsens
01:40 PM – 02:00 PMPierre Labbé, CFO
IMV Inc
Dr. Jim Lu, President
GoPath Laboratories
02:00 PM – 02:20 PMProf. Xiaoping Du, Chairman
DMT, Inc.
Greg Stafford, CFO
NURITAS
02:20 PM – 02:40 PMIan Wilson, CEO
IMAGINAB
Dongpo Cai, MD, Ph.D, CMO
Accendatech
02:40 PM – 03:00 PMFilippo Petti, CEO
CELYAD
Charles Wu, PhD CEO
Intact Genomics, Inc.
03:00 PM – 03:40 PMCoffee Break & Bio-Partnering
03:40 PM – 05:50 PMMODERATOR (Utopia Ballroom A&B)
Dr. Wenqing Yao
Executive VP, Incyte
ROAD SHOW SESSION
Track A
MODERATOR (Euphoria)
Cong Xu, MD, Ph.D
VP, Lilly Asia Ventures
ROAD SHOW SESSION
Track B
03:40 PM – 04:00 PMDr. Russell Dahl, CEO
Neurodon LLC
Philip Gao, Ph.D., President
Nuovo Biologics, LLC
04:00 PM – 04:20 PMDr. Zhendong Jin, CEO
Professor, U of Iowa
InnoBioPharma
Dr. Yulia Komarova
Associate Professor, UIC
Komarova Lab
04:20 PM – 04:40 PMDr. Jennifer Wu
Mary and Patrick Scanlan Professor, Northwestern
CanCure LLC
Dr. Kaimin Cai, CEO
Iria Pharma, LLC
04:40 PM – 05:00 PMDr. Zhiyong Yang, CEO
FZata, Inc.
Brad Prosek, Senior VP, Corporate Development
Constellation Pharma
05:00 PM – 05:20 PMDr. William Zhao, CEO
Meridian Lab
Dr. Bruce L. Riser, CEO
BLR-Bio, LLC
05:20 PM – 05:40 PMDr. Lei Xiao, CEO
Innovative Cellular Therapeutics
Dr. David J. Josfield, CSO
Boost Therapeutics Inc
05:40 PM – 05:45 PMClosing remarks for Bio-Partnering ForumClosing remarks for Bio-Partnering Forum
06:00 PM – 08:30 PMNetworking & Bio-Partnering Reception (Food and beverage served):
Sparx Therapeutics (700 E. Business Center Dr., Mt Prospect, IL 60056)
31
May
2019

(Friday)

Scientific Symposium
08:30 AM – 11:40 AMSYMPOSIUM CHAIR & MODERATOR (Utopia Ballroom A&B)
Dr. Ying Liu 
Associate Professor, University of Illinois at Chicago & Former President, SAPA-MW
08:30 AM – 08:40 AMWelcome & Opening Remarks
Dr. Ying Liu
Associate Professor, University of Illinois at Chicago & Former President, SAPA-MW
08:40 AM – 09:20 AMSymposium Keynote Address (1)
Dr. Wenbin Lin
James Franck Professor, The University of Chicago
09:20 AM – 10:00 AMSynthetic Lethality as an Engine for the Development of Next Generation Cancer Drug
Dr. Alan Huang,
CSO, Tango Therapeutics
10:00 AM – 10:20 AMBreak & Networking
10:20 AM – 11:40 AMMODERATOR (Utopia Ballroom A&B)
Dr. Thomas von Geldern,
President, Embedded Consulting
10:20 AM – 11:00 AMA Structure-based Approach Toward the Development of Chaperone-selective Inhibitors
Dr. Brian Blagg
Charles Huisking Professor of Chemistry and Biochemistry, University of Notre Dame
11:00 AM – 11:40 AMSymposium Keynote Address (4)
Dr. Lyu Aiping,
Dean and Kennedy Y.H. Wong Professor, Hong Kong Baptist University , School of Chinese Medicine
11:40 AM – 01:00 PMLunch & Job Fair Presentations
(Utopia Ballroom C&D)
01:00 PM – 02:20 PMMODERATOR (Utopia Ballroom A&B)
Dr. Lyu Aiping,
Dean and Kennedy Y.H. Wong Professor, Hong Kong Baptist University , School of Chinese Medicine
01:00 PM – 01:40 PMCD73: an Emerging Checkpoint for Cancer Immunotherapy
Bin Zhang, MD, PhD,
Professor of Medicine, School of Medicine, Northwestern University
01:40 PM – 02:20 PMSymposium Keynote Address (6)
Dr. Thomas von Geldern,
President, Embedded Consulting
02:20 PM – 03:00 PMSymposium Keynote Address (7)
Dr. Jun Huang
Assistant Professor, The University of Chicago
03:00 PM – 05:30 PMDr. Gang Cheng
Associate Professor, University of Illinois at Chicago & President-Elect, SAPA-MW
Closing Remark and Job Fair

Projected Attendees

Participating Venture Capital

1. Third Rock Partners
2. AbbVie Ventures
3. Hillhouse Capital Group
4. Sangel Capital
5. Oceanpine Healthcare Fund

6. VI Ventures
7. Good Health Capital
8. Sunforest Capital
9. Yuanming Capital
10. Bioventure

11. Good AI Capital
12. Lilly Asia Ventures
13. Hofon Capital

Participating Companies

  • 3D Med
  • Abbisko Therapeutics
  • AbbVie
  • ADURO BIOTECH
  • Affimed N.V.
  • AntiCancer Biotech
  • Arrow Immune
  • AveXis
  • Beijing SUNHOPE IP Ltd.
  • BIOINVENT INTERNATIONAL
  • BrainXell
  • CanCure
  • Celyad
  • Constellation
  • CPL
  • CurMed
  • DESTINY PHARMA
  • Dupage Medical Technology, Inc.
  • ELPISCIENCE BIOPHARMA
  • FZata, Inc
  • GoPath Laboratories
  • HRYZ BIOTECH Co.
  • ImaginAb
  • Immunicum
  • IMV Inc.
  • InnoBioPharma, LLC
  • Institute of Materia Medica, CAS
  • Intact Genomics, Inc.
  • Iria Pharma
  • Jemincare Therapeutics
  • Komarova Lab
  • KPC Pharmaceutical
  • Meridian Lab
  • Morphogene
  • Neurodon LLC
  • Nuovo Biologics
  • NURITAS
  • Opsens
  • Prelude Therapeutics
  • PRUNUS Therapeutics
  • Qugene Scientific
  • Repligen Inc
  • RGENIX
  • Rimo
  • Sparx Therapeutics
  • Xi’an Xingfu Pharmaceutical

Huddle for Warmth, Building a Global Leading Biomedical Hub in Midwestern America

When most people think about “Midwestern America”, they associate images of flat plains and sprawling farmlands, but surprisingly not many think of the incredible skylines of Chicago. Today “America’s Heartland” is evolving at an ever increasing rate. Not only was Chicago named the best city to live in by several magazines, but also the Midwest is emerging as one of the top global hubs for biomedical innovation – a healthy ecosystem for biotech research.

Within the heart of this ecosystem lies an incredible pool of talent, which has driven tremendous progress on fundamental research and applied life sciences. Their hard work and efforts have translated into numerous life-changing medicines. This is in large part a testament to the top- notch institutions in the area such as the University of Chicago, Northwestern University, University of Illinois, University of Wisconsin, University of Michigan , and Washington University in St. Louis, among many others that place immense emphasis on strong life-science related research. The surrounding large cap pharmaceutical companies such as AbbVie, Abbott, Baxter, and Eli Lilly contribute research muscle as well as business and management expertise, an essential foundation to this hub.

That being said, scientific accomplishments and large pools of talent are necessary but not sufficient in building an ideal ecosystem for the biotech community, particularly when compared to Boston and the Bay area. To attract early stage venture capital resources and foster an environment that supports innovative startups, we need to “Huddle for Warmth”. What that means is building in all the other factors required for fostering fast-paced growth and development to become the leading global hub for biomedical innovation. The academic institutions and industry researchers need to have a more interwoven, productive, and sustainable form of collaboration. We’re looking for more support from clinical research and development, regulatory affairs, business development, commercial/financial experts, and even a strong voice in the realm of government & politics. This conference attempts to dial in all the resources and connections to help generate the synergy which will fuel this wealthy ecosystem of scientific advancement. This would establish the framework to effectively translate groundbreaking discoveries to enviable assets that are attractive to capitals around the world, including China.

Date & Venue

Renaissance Schaumburg Convention Center Hotel
(1551 Thoreau Dr., Schaumburg, IL 60173, USA)

THE 11TH YAO YUAN CONFERENCE

PHOTO GALLERY